Intraocular neovascularization

Journal of Japanese Ophthalmological Society

Volumn 101, Issue 12, 1997, Pages 906-926

  Inomata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Activator protein 1 (AP1); Interleukin 8 (IL 8); Neovascularization; Nuclear factor kappa B (NF xB); Vascular endothelial growth factor (VEGF)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

CELL PROLIFERATION; CILIARY BODY EPITHELIUM; CONFERENCE PAPER; GENE EXPRESSION REGULATION; GLIA CELL; GROWTH REGULATION; PATHOPHYSIOLOGY; PERICYTE; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION; RETINA NERVE CELL; VASCULAR ENDOTHELIUM;

ADULT; ANIMALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERLEUKIN-8; LYMPHOKINES; RATS; RETINAL NEOVASCULARIZATION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031468523     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (100)

1. Simorre-Pinatel V, Guerrin M, Chollet P, Penary M, Clamens S, Malecaze F, et al: Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci 35: 3393-3400, 1994.
2. Michaelson IC: The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 68: 137-180, 1948.
3. Ashton N, Ward B, Serpell G: Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol 38: 397-432, 1954.
4. Ashton N, Blach R: Studies on developing retinal vessels. VIII. Effect of oxygen on the retinal vessels of the ratling. Br J Ophthalmol 45: 321-340, 1961.
5. Ashton N: Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The XX Francis I. Proctor Lecture. Am J Ophthalmol 62: 412-435, 1966.
6. Ashton N: Some aspects of the comparative pathology of oxygen toxicity in the retina. Donders Lecture. 1967. Br J Ophthalmol 52: 505-531, 1968.
7. Wise GN: Retinal neovascularization. Trans Am Ophthalmol Soc 54: 729-826, 1956.
8. Folkman J, Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
9. Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14: 53-65, 1977.
10. Federman JL, Brown GC, Felberg NT, Felton SM: Experimental ocular angiogenesis. Am J Ophthalmol 89: 231-237, 1980.
11. Folkman J, Haudenschild C: Angiogenesis in vitro. Nature 288: 551-556, 1980.
12. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1989.
13. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
14. Tischer E, Gospodarowiez D, Mitchell R, Silva M, Schilling J, Lau K, et al: Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 165: 1198-1206, 1989.
15. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW: The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47: 211-218, 1991.
16. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89: 244-253, 1992.
17. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
18. Ladoux A, Frelin C: Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 195: 1005-1010, 1993.
19. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983.
20. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, et al: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312, 1989
21. Glaser BM, Campochiaro PA, Davis Jr JL, Sato M : Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol 103: 1870-1875, 1985.
22. Jacobson B, Basu PK, Hasany SM: Vascular endothelial cell growth inhibitor of normal and pathologic human vitreous. Arch Ophthalmol 102: 1543-1545, 1984.
23. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA: An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86: 4544-4548, 1989.
24. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM: Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology 97: 1321-1328, 1990.
25. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM: Scatter pholocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology 97: 1329-1333, 1990.
26. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, et al: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 143: 574-584, 1994
27. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E: Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72: 638-645, 1995.
28. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, et al: Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103: 1820-1828, 1996.
29. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, et al: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84: 9233-9237, 1987.
30. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, et al: Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167: 1883-1893, 1988.
31. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, et al: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992.
32. Strieter RM, Kunkel SL, Einer VM, Martonyi CL, Koch AE, Polverini PJ, et al: Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 141: 1279-1284, 1992.
33. Einer SG, Einer VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM: Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 14: 1045-1053, 1995.
34. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? -G.H.A. Clowes Memorial Award Lecture. Cancer Res 46: 467-473, 1986.
35. Ishibashi T, Murata T, Sueishi K, Inomata H: Morphologic study of angiogenesis in vitro. In Vitro Cell Dev Biol 29 A: 91-93, 1993.
36. Inomata H, Smelser GK, Polack FM: Corneal vascularization in experimental uveitis and graft rejection. Invest Ophthalmol 10: 840-850, 1971.
37. Laterra J, Guerin C, Goldstein GW: Astrocytes induce neural microvascular endothelial cells to form capillary-like structures in vitro. J Cell Physiol 144: 204-215, 1990.
38. Risau W, Sariola H, Zerwes H-G, Sasse J, Ekblom P, Kemler R, et al: Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102: 471-478, 1988.
39. Gariano RF, Iruela-Arispe ML, Hendrickson AE: Vascular development in primate retina: Comparison of laminar plexus formation in monkey and human. Invest Ophthalmol Vis Sci 35: 3442-3455, 1994.
40. Chan-Ling T, Halasz P, Stone J: Development of retinal vasculature in the cat: Processes and mechanisms. Curr Eye Res 9: 459-478, 1990.
41. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K: The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates. Lab Invest 74: 68-77, 1996.
42. Hsu S-M, Raine L, Fanger H: Use of avidinbiotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
43. Minchenko A, Bauer T, Salceda S, Caro J: Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71: 374-379, 1994.
44. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, et al: Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neuroscience 15: 4738-4747, 1995.
45. Chan-Ling T, Stone J: Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. Invest Ophthalmol Vis Sci 33: 2148-2159, 1992.
46. Phelps DL: Oxygen and developmental retinal capillary remodeling in the kitten. Invest Ophthalmol Vis Sci 31: 2194-2200, 1990.
47. Iwasaki M, Inomata H: Relation between superficial capillaries and foveal structures in the human retina. Invest Ophthalmol Vis Sci 27: 1698-1705, 1986.
48. Iwasaki M, Inomata H: Regional variation of superficial and radial peripapillary capillaries in the human retina. Microcirculation -an update, vol 2, In: Tsuchiya M, et al. (Eds), Elsevier Science Publishers, Amsterdam, 73-76, 1987.
49. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, et al: Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 112: 1476-1482, 1994.
50. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH: Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92: 905-909, 1995.
51. 1. Cancer Res 52: 4821-4823, 1992.
52. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD: Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: Synergistic interaction with hypoxia. Circulation 92: 11-14, 1995.
53. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New Eng J Med 331: 1480-1487, 1994.
54. Tawara A, Kubota T, Takenouchi T, Sakamoto T, Hata Y, Inomata H: Iris and trabecular neovascularization caused by anterior segment ischemia in rabbits. Invest Ophthalmol Vis Sci 37 (suppl): s 824, 1996.
55. Ruskell GL: Anterior communications between the intrinsic and extrinsic arteries of the rabbit eye. Anat Rec 142: 147-154, 1962.
56. Alroy J, Goyal V, Skutelsky E: Lectin histo chemistry of mammalian endothelium. Histochemistry 86: 603-607, 1987.
57. Ishibashi T, Hata Y, Yoshikawa H, Nakagawa K, Sueishi K, Inomata H: Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefe's Arch Clin Exp Ophthalmol 235: 159-167, 1997.
58. Cogan DG, Toussaint D, Kuwabara T: Retinal vascular pattern. IV. Diabetic retinopathy. Arch Ophthalmol 66: 366-378, 1961.
59. Kuwabara T, Cogan DG: Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch Ophthalmol 69: 492-502, 1963.
60. Kuwabara T, Cogan DG: Retinal vascular patterns. VII. Acellular change. Invest Ophthalmol 4: 1049-1058, 1965.
61. de Oliveira F: Pericytes in diabetic retinopathy. Br J Ophthalmol 50: 134-143, 1966.
62. Wong HC, Boulton M, Marshall J, Clark P: Growth of retinal capillary endothelia using pericyte conditioned medium. Invest Ophthalmol Vis Sci 28: 1767-1775, 1987.
63. Sato Y, Rifkin DB: Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-β 1-like molecule by plasmin during coculture. J Cell Biol 109: 309-315, 1989.
64. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB: Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system J Cell Biol 111: 757-763, 1990.
65. Murata T, Ishibashi T, Inomata H, Sueishi K: Media conditioned by coculture of pericytes and endothelial cells under a hypoxic state stimulate in vitro angiogenesis. Ophthalmic Res 26: 23-31, 1994.
66. Orlidge A, D'Amore PA: Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105: 1455-1462, 1987.
67. Sakuda H, Nakashima Y, Kuriyama S, Sueishi K: Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis: A relationship to transforming growth factor-β 1. Am J Pathol 141: 1507-1516, 1992.
68. Penfold PL, Provis JM, Madigan MC, van Driel D, Billson FA: Angiogenesis in normal human retinal development: The involvement of astrocytes and macrophages. Graefe's Arch Clin Exp Ophthalmol 228: 255-263, 1990.
69. Nork TM, Wallow IHL, Sramek SJ, Anderson G: Müller's cell involvement in proliferative diabetic retinopathy. Arch Ophthalmol 105: 1424-1429, 1987.
70. Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H: Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 27: 48-52, 1995.
71. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K: The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retina. Lab Invest 74: 819-825, 1996.
72. Hata Y, Nakagawa K, Ishibashi T, Inomata H, Ueno H, Sueishi K: Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Arch 426: 479-486, 1995.
73. Blanchard KL, Acquaviva AM, Galson DL, Bunn HF, Hypoxic induction of the human erythropoietin gene: Cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol 12: 5373-5385, 1992.
74. Karakurum M, Shreeniwas R, Chen J, Pinsky D, Yan S-D, Anderson M, et al: Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 93: 1564-1570, 1994.
75. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, et al: The human gene for vascular endothelial growth factor. J Biol Chem 266: 11947-11954, 1991.
76. Goldberg MA, Schneider TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269: 4355-4359, 1994.
77. Angel P, Hattori K, Smeal T, Karin M: The jun proto-oncogene is positively autoregulated by its products, Jun/AP-1. Cell 55: 875-885, 1988.
78. Carter BZ, Malter JS: Biology of disease. Regulation of mRNA stability and its relevance to disease. Lab Invest 65: 610-621, 1991.
79. 2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci 37: 1311-1321, 1996.
80. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, et al: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92: 10457-10461, 1995.
81. Pierce EA, Foley ED, Smith LEH: Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114: 1219-1228, 1996.
82. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, et al: Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-NB is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269: 13289-13295, 1994.
83. Baeuerle PA, Henkel T: Function and activation of NF-N-B in the immune system. Ann Rev Immunol 12: 141-179, 1994.
84. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I, et al: Characterization of a functional NF-NB site in the human interleukin 1β promoter: Evidence for a positive autoregulatory loop. Mol Cell Biol 13: 6231-6210, 1993.
85. Lindner V, Collins T: Expression of NF-NB and INB-α by aortic endothelium in an arterial injury model. Am J Pathol 148: 427-438, 1996.
86. Lenardo MJ, Baltimore D: NF-NB: A pleiotropic mediator of inducible and tissuespecific gene control. Mini review. Cell 58: 227-229, 1989.
87. Koong AC, Chen EY, Giaccia AJ: Hypoxia causes the activation of nuclear factor NB through the phosphorylation of INBα on tyrosine residues. Cancer Res 54: 1425-1430, 1994.
88. Shono T, Ono M, Izumi H, Jimi S, Matsushima K, Okamoto T, et al: Involvement of the transcription factor NF-NB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 16: 4231-4239, 1996.
89. Yoshida A, Yoshida S, Hata Y, Ishibashi T, Inomata H: Expression of NF-NB in retinal neovascularization: Possible involvement of interleukin-8. Invest Ophthalmol Vis Sci 38 (suppl): s 611, 1997.
90. Blackwell TS, Holden EP, Blackwell TR, DeLarco JE, Christman JW: Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: Association with nuclear factor NB activation. Am J Respir Cell Mol Biol 11: 464-472, 1994.
91. Tsuruma T, Yagihashi A, Hirata K, Matsuno T, Zou XM, Sasaki K, et al: Evaluation of plasma IL-8 (CINC) concentration during ischemia and after reperfusion in the small intestine. Transplantation Proceedings 28: 1917-1918, 1996
92. Wakabayashi Y, Shono T, Isono M, Hori S, Matsushima K, Ono M, et al: Dual pathways to tubular morphogenesis of vascular endothelial cells by human glioma cells: Vascular endothelial growth factor/basic fibroblast growth factor and interleukin-8. Jpn J Cancer Res 86: 1189-1197. 1995.